Adding bevacizumab to initital glioblastoma treatment doesn't improve overall survival
Results of a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group determined that adding bevacizumab to initial treatment for glioblastoma did not improve patient overall survival or progression-free ...
Feb 19, 2014
0
0